Pulmonary hemorrhage with capillaritis secondary to mycophenolate mofetil in a heart-transplant patient

Archives of Pathology and Laboratory Medicine

Volumn 137, Issue 11, 2013, Pages 1684-1687

  Gorgan, Maria ^a   Bockorny, Bruno ^a   Lawlor, Michael ^b   Volpe, John ^c   Fiel Gan, Mary ^a  

^a HARTFORD HOSPITAL   (United States)

^b Infectious Diseases   (United States)

^c Radiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ARTICLE; BLEEDING; CASE REPORT; CHEMICALLY INDUCED DISORDER; HEART TRANSPLANTATION; HUMAN; LUNG DISEASE; MALE; MIDDLE AGED; PATHOLOGY; VASCULITIS;

HEART TRANSPLANTATION; HEMORRHAGE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG DISEASES; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; TACROLIMUS; VASCULITIS;

EID: 84887835080     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2012-0460-CR     Document Type: Article

References (18)

1. Lenner R, Padilla M, Teirstein AS, Gass A, Schilero GI. Pulmonary complications in cardiac transplant recipients. Chest 2001;120(2):508-513
2. Atasever A, Bacakoglu F, Uysal FE, et al. Pulmonary complications in heart transplant recipients. Transplant Proc. 2006;38(5):1530-1534
3. Knisley BL, Mastey LA, Collins J, Kuhlman JE. Imaging of cardiac transplantation complications. Radiographics. 1999;19(2):321-341.
4. Verres G, Bruce CJ, Kutzke K, et al. Acute thrombus formation as a complication of right ventricular biopsy. J Am Soc Echocardiogr. 2010;23(10): 1039-1044
5. Green RJ, Ruoss, SJ, Kraft SA, Berry GJ, Raffin TA. Pulmonary capillaritis and alveolar hemorrhage: update on diagnosis and management. Chest. 1996; 110(5):1305-1316
6. Cuellar MA. Drug-induced vasculitis. Curr Rheumatol Rep. 2002;4(1):55- 59
7. Dhillon SS, Singh D, Doe N, Qadri AM, Ricciardi S, Schwartz MI. Diffuse alveolar hemorrhage and pulmonary capillaritis due to propylthiouracil. Chest. 1999;116(5):1485-1488
8. Nicolls MR, Terada LS, Tuder RM, Prindivillle SA, Schwartz MI. Diffuse alveolar hemorrhage with underlying pulmonary capillaritis in the retinoic acid syndrome. Am J Respir Crit Care Med. 1998;158(4):1302-1305
9. Gross DC, Sasaki TM, Buick MK, Light JA. Acute respiratory failure and pulmonary fibrosis secondary to administration of mycophenolate mofetil. Transplantation. 1997;64(11):1607-1609
10. Morrissey P, Gohh R, Madras P, Monaco AP. Pulmonary fibrosis secondary to administration of mycophenolate mofetil. Transplantation. 1998;65(10):1414
11. Johnston A, Holt DW. Immunosuppressant drugs - role of therapeutic drug monitoring. Br J Clin Pharmacol. 2001;52(1)(suppl):61S-73S
12. Fulton B, Markham A. Mycophenolate mofetil: a review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation. Drugs. 1996;51(2):278-298
13. Jiang X, Khursigara G, Rubin RL. Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils. Science. 1994;266(5186):810-813
14. Von Schmiedeberg S, Goebel C, Gleichmann E, Uetrecht J. Neutrophils and drug metabolism [letter]. Science. 1995;268(5210):585-586
15. Lee E, Kariya K, Miki Y, Katsljra H. Mechanism of inactivation of myeloperoxidase by propylthiouracil. Biochem Pharmacol. 1990;39(9):1467-1471
16. Langford CA, Tallar-Williams C, Sneller MC. Mycophenolate mofetil for remission maintenance in the treatment of Wegener's granulomatosis. Arthritis Rheum. 2004;51(2):278-283
17. Nowak R, Gobel U, Klooker P, Hergesell O, Andrassy K, van derWoude FJ. Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with renal involvement. J Am Soc Nephrol. 1999;10(9):1965-1971
18. Sovijärvi AR, Lemola M, Stenius B, Idänpään- Heikkilä J. Nitrofurantoininduced acute, subacute and chronic pulmonary reactions. Scand J Respir Dis. 1977;58(1):41-50